Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Bristol-Myers Squibb Receives FDA Approval for New Formulation of Antiretroviral Reyataz

October 24, 2006

Bristol-Myers Squibb on Friday announced that it has received FDA approval for a single 300 mg capsule formulation of its protease inhibitor Reyataz to be taken as part of combination therapy, Reuters reports. The new formulation is taken once daily and likely will be available within one week, according to BMS (Reuters, 10/20). Reyataz, known generically as atazanavir, is used in second-line HIV/AIDS drug treatments. Under World Health Organization guidelines, atazanavir is best taken with a booster drug, usually Abbott Laboratories' ritonavir (Kaiser Daily HIV/AIDS Report, 2/15). According to BMS, the 300 mg formulation can replace the twice daily 150 mg formulations of Reyataz for people who previously have taken antiretroviral drugs, people who will be taking tenofovir disoproxil fumarate and people who have never taken efavirenz as part of their drug regimens (BMS release, 10/20).

Back to other news for October 24, 2006


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2006 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on HIV Medications
More News and Research on Atazanavir (Reyataz)
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement